Skip to main content
. 2021 May 6;11(5):834. doi: 10.3390/diagnostics11050834

Figure 3.

Figure 3

Diagnostic tests considered by the survey participants in patients with heart failure and suspicion of cardiac amyloidosis. CMR cardiac magnetic resonance, ECG electrocardiogram, LC light chain. Cardiac biomarkers are represented by NT-pro BNP and troponin.